CHONDROGEN Trademark

Trademark Overview

On Wednesday, November 19, 2008, a trademark application was filed for CHONDROGEN with the United States Patent and Trademark Office. The USPTO has given the CHONDROGEN trademark a serial number of 77617756. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 18, 2020. This trademark is owned by Osiris Therapeutics, Inc.. The CHONDROGEN trademark is filed in the Pharmaceutical Products category with the following description:

Progenitor cells capable of differentiating into cartilage tissue cells for use in therapeutic, medical or clinical cellular therapies
chondrogen

General Information

Serial Number77617756
Word MarkCHONDROGEN
Filing DateWednesday, November 19, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 18, 2020
Registration Number4529732
Registration DateTuesday, May 13, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2010

Trademark Statements

Goods and ServicesProgenitor cells capable of differentiating into cartilage tissue cells for use in therapeutic, medical or clinical cellular therapies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 18, 2020
Primary Code005
First Use Anywhere DateTuesday, November 22, 2005
First Use In Commerce DateTuesday, November 22, 2005

Trademark Owner History

Party NameMESOBLAST INTERNATIONAL SARL
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMEYRIN 1217
CH
Party NameOsiris Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressColumbia, MD 21046
Party NameOsiris Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressColumbia, MD 21046
Party NameOsiris Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressColumbia, MD 21046

Trademark Events

Event DateEvent Description
Friday, December 18, 2020CANCELLED SEC. 8 (6-YR)
Monday, May 13, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, May 18, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 18, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 7, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 7, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 23, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 13, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, April 10, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 9, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, April 9, 2014ASSIGNED TO LIE
Tuesday, April 8, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 28, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, February 17, 2014USE AMENDMENT FILED
Monday, February 17, 2014TEAS STATEMENT OF USE RECEIVED
Thursday, August 22, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2013EXTENSION 5 GRANTED
Wednesday, August 14, 2013EXTENSION 5 FILED
Wednesday, August 14, 2013TEAS EXTENSION RECEIVED
Wednesday, August 14, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 21, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 20, 2013EXTENSION 4 GRANTED
Tuesday, February 12, 2013EXTENSION 4 FILED
Tuesday, February 12, 2013TEAS EXTENSION RECEIVED
Tuesday, August 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 20, 2012EXTENSION 3 GRANTED
Wednesday, August 15, 2012EXTENSION 3 FILED
Wednesday, August 15, 2012TEAS EXTENSION RECEIVED
Tuesday, March 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, March 11, 2012EXTENSION 2 GRANTED
Tuesday, February 14, 2012EXTENSION 2 FILED
Friday, March 9, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 14, 2012TEAS EXTENSION RECEIVED
Thursday, August 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 9, 2011EXTENSION 1 GRANTED
Tuesday, August 9, 2011EXTENSION 1 FILED
Tuesday, August 9, 2011TEAS EXTENSION RECEIVED
Tuesday, February 15, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 21, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2010PUBLISHED FOR OPPOSITION
Friday, November 12, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 10, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 5, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 5, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 5, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 16, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, October 16, 2010NON-FINAL ACTION E-MAILED
Saturday, October 16, 2010NON-FINAL ACTION WRITTEN
Friday, September 24, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 23, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 23, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 23, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 23, 2010NON-FINAL ACTION E-MAILED
Tuesday, March 23, 2010NON-FINAL ACTION WRITTEN
Thursday, February 25, 2010LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, August 20, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 20, 2009ASSIGNED TO LIE
Friday, February 20, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 20, 2009LETTER OF SUSPENSION E-MAILED
Friday, February 20, 2009SUSPENSION LETTER WRITTEN
Wednesday, February 18, 2009ASSIGNED TO EXAMINER
Monday, November 24, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

chondrogen cells medical clinical therapies therapeutic cellular tissue capable differentiating cartilage